Keyphrases
Genomic Instability
100%
Dasatinib
100%
Mammary Tumor Cells
100%
NEDD9
100%
Polyomavirus
54%
Mouse Mammary Tumor Virus
54%
Tumor
18%
Tumor Growth
18%
Mammary Tumor
18%
Genetic Model
9%
Genotype
9%
Cancer Cells
9%
Tumor Metastasis
9%
Signaling Molecules
9%
Support Activities
9%
Cancer-associated Fibroblasts
9%
Src Kinase Inhibitor
9%
Cell-derived
9%
Scaffold Protein
9%
Tumor Cell Invasion
9%
Tumor Aggressiveness
9%
Lung Metastasis
9%
Anchorage-independent Growth
9%
Tail Vein Injection
9%
Multiple Cancers
9%
Cell Cycle Defects
9%
Three-dimensional Matrix
9%
Aggressive Phenotype
9%
Src Activation
9%
Cancer Pathways
9%
In Vivo Microenvironment
9%
Reinjection
9%
Aggressive Growth
9%
Mitotic Defects
9%
Initial Delay
9%
HEF1
9%
Supportability Evaluation
9%
Medicine and Dentistry
Breast Tumor
100%
Mouse Mammary Tumor Virus
100%
Polyomavirus
100%
Dasatinib
100%
Neoplasm
83%
Malignant Neoplasm
16%
Biological Marker
16%
Cancer Cell
16%
Intravenous Drug Administration
16%
Cell Cycle
16%
Tumor Progression
16%
Tumor Cell
16%
Metastatic Carcinoma
16%
Phosphotransferase Inhibitor
16%
Cell Invasion
16%
Proteus Syndrome
16%
Anchorage Independent Growth
16%
Lung Metastasis
16%
Tail Vein
16%
Signaling Protein
16%
Tumor Growth
16%
Scaffold Protein
16%
Protein Kinase B
16%
Fibroblast
16%
Biochemistry, Genetics and Molecular Biology
Genetics
100%
Mouse Mammary Tumor Virus
100%
Polyomavirus
100%
Dasatinib
100%
Tumor Progression
33%
Genetic Model
16%
Genotyping
16%
Signaling Protein
16%
Cancer Cell
16%
Cell Cycle
16%
Cell Invasion
16%
Anchorage Independent Growth
16%
Phosphotransferase
16%
Kinase
16%
Protein Kinase B
16%
Scaffold Protein
16%
Fibroblast
16%